BANK OF MONTREAL /CAN/ - MARINUS PHARMACEUTICALS INC ownership

MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 4 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of MARINUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$16,000
+14.3%
6,731
+2.6%
0.00%
Q4 2019$14,000
+100.0%
6,563
+49.6%
0.00%
Q3 2019$7,000
-58.8%
4,386
+4.2%
0.00%
Q2 2019$17,000
+1600.0%
4,211
+1153.3%
0.00%
Q1 2019$1,0000.0%336
-34.4%
0.00%
Q4 2018$1,000
-66.7%
512
+104.0%
0.00%
Q3 2018$3,000
+50.0%
251
-3.1%
0.00%
Q2 2018$2,0002590.00%
Other shareholders
MARINUS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 1,340,588$1,354,0000.34%
BOOTHBAY FUND MANAGEMENT, LLC 78,662$79,0000.02%
Orbimed Advisors 567,600$573,0000.01%
Acrospire Investment Management LLC 14,323$14,0000.01%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 10,000$10,0000.00%
Virtu KCG Holdings LLC 49,847$50,0000.00%
NEXT Financial Group, Inc 2,670$3,000,0000.00%
Squarepoint Ops LLC 13,000$13,0000.00%
FRANKLIN RESOURCES INC 2,182,185$2,204,0000.00%
A.R.T. Advisors, LLC 16,830$16,0000.00%
View complete list of MARINUS PHARMACEUTICALS INC shareholders